Acasti Pharma Inc. (ACST.V)
Stock analysis · TSXV · Healthcare · Biotechnology
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
1.22
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
Acasti Pharma Inc. (ACST.V) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Most Recent
Jun 19, 2023
EPS $-0.37 vs est. $-0.16
Missed by $0.21
Proprietary Signals
About Acasti Pharma Inc.
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap